Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Aug 15, 2022 10:01am
193 Views
Post# 34896279

RE:RE:RE:RE:SP

RE:RE:RE:RE:SPMM - based on this morning's share price activity it would appear that Seto is going to be doing a dilutive issue likely in the range of $0.40 or lower per share.  So much for being a man of his word.  So well below the $2 to $3 per share that you had been suggesting (I agree with your issue price).  Disgusting?  Yes.  Let's see what the rhetoric surrounding the "strategic" placement is this time.  I don't believe a word of it as this will be the third "strategic" placement.  Minimum disclosure coupled with no real promotion provides them this opportunity.  And the insiders don't care - they are privy to everything including the redacted Baxter agreement from two plus years ago.  As Gorf says they don't care what the share price is since they know the end game and the value to be realized.  Until we reach that point the party favors will be doled out to "strategic" parties.

And while that happens the planted idiots carry on about dolphins and cats in heaven and their preferences for who is admitted there.  Gorf you are 100% right - their purpose is to dilute real posters with their garbage.  So the only option for the real shareholders is to wait and see the issue price and then pick up shares at the stupidly low levels.  Only way to fight the dilution from the "strategic" placements.
<< Previous
Bullboard Posts
Next >>